Evidence map›Paper›PMID 40153596›Full record

Trial reportAnnals of the American Thoracic Society2025

Intermittent versus Daily Therapy for Noncavitary

Taku Nakagawa, Kohei Fujita, Mari Miki, Akihiro Ito, Ho Namkoong, Takanori Asakura, Kozo Morimoto, Naoki Hasegawa, Toshiyuki Kita, Akira Watanabe and 13 more

Abstract readRandomized Controlled TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Annals of the American Thoracic Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Treatment strategies forBreathe (Sheffield, England) · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Taku NakagawaDepartment of Respiratory Medicine, NHO Higashinagoya National Hospital, Aichi, Japan.ORCID 0000-0002-4157-1112
Kohei FujitaDepartment of Respiratory Medicine, NHO Kyoto Medical Center, Kyoto, Japan.ORCID 0000-0002-6902-9085
Mari MikiDepartment of Respiratory Medicine, NHO Osaka Toneyama Medical Center, Osaka, Japan.ORCID 0000-0002-6642-4987
Akihiro ItoDepartment of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, Okayama, Japan.
Ho NamkoongDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0001-6181-4284
Takanori AsakuraDepartment of Clinical Medicine (Laboratory of Bioregulatory Medicine), Kitasato University School of Pharmacy, Tokyo, Japan.ORCID 0000-0003-3122-6937
Kozo MorimotoRespiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.ORCID 0000-0002-8239-9275
Naoki HasegawaDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0003-0717-7450
Toshiyuki KitaDepartment of Respiratory Medicine, NHO Kanazawa Medical Center, Ishikawa, Japan.ORCID 0000-0001-6158-7683
Akira WatanabeDepartment of Respiratory Medicine, NHO Ehime Medical Center, Ehime, Japan.
Kazunari TsuyuguchiDepartment of Infectious Diseases, Clinical Research Center, and.
Masahiro KawashimaCenter for Pulmonary Diseases, NHO Tokyo National Hospital, Tokyo, Japan.
Ayako ShiozawaDepartment of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan.ORCID 0000-0003-3258-2570
Satoru WatanabeDivision of Respiratory Medicine, NHO Shibukawa Medical Center, Gunma, Japan.
Atsuo SatoDepartment of Respiratory Medicine, NHO Minami Kyoto Hospital, Kyoto, Japan.
Tatsuo KatoDivision of Respiratory Medicine, NHO Nagara Medical Center, Gifu, Japan.
Yoshifumi KimizukaDivision of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.ORCID 0000-0002-4026-7506
Hiroaki HaradaDivision of Respiratory Medicine, NHO Higashihiroshima Medical Center, Hiroshima, Japan.
Kaori FujitaDepartment of Respiratory Medicine, NHO Okinawa Hospital, Okinawa, Japan.
Akiko M SaitoClinical Research Center, NHO Nagoya Medical Center, Aichi, Japan; and.ORCID 0000-0003-3723-8445
Hiroya HashimotoClinical Research Center, NHO Nagoya Medical Center, Aichi, Japan; and.ORCID 0000-0003-1865-4953
Yoshikazu InoueClinical Research Center, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.ORCID 0000-0003-3994-874X
Kenji OgawaDepartment of Respiratory Medicine, NHO Higashinagoya National Hospital, Aichi, Japan.ORCID 0000-0002-4247-6862

Funding

Grant-in-Aid for Clinical Research from the National Hospital Organization
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAntitubercular AgentsClarithromycinEthambutolLung DiseasesMycobacterium avium ComplexMycobacterium avium-intracellulare InfectionRifampinAgedDrug Administration ScheduleDrug Therapy, CombinationFemaleHumansJapanMaleMiddle AgedAnti-Bacterial AgentsAntitubercular AgentsClarithromycinEthambutolRifampinadverse drug reactionhealth-related quality of lifeintermittent treatmentnontuberculous mycobacteria

Identifiers

PMID40153596
PMCPMC12329335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.